Regeneron Pharmaceuticals, Inc.

REGN

HealthcareNMS$79.2B

REGN SEC filings last scanned 13 May 2026, 22:50 UTC

CEO Timeline

Leonard Schleifer, M.D., Ph.D.Current

CEO since at least Mar 2005 (no leadership change found in filings)